Trial Profile
A comparison of the Effects of Vytorin (Ezetimibe and Simvastatin) versus Lipitor (Atorvastatin) in inducing changes to levels of novel serum biomarkers associated with Coronary Heart Disease risk.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jul 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Biomarker; Pharmacodynamics
- Acronyms VYTUL
- 05 Jul 2016 New trial record